Ownership Summary
Harvard Bioscience Inc (NASDAQ:HBIO) has 3 institutional investors that have filed 13F reports for the period ending March 2026.
- They owned 5.3% of outstanding stock in March 2026, down from 39.8% the prior quarter.
- Their total shares held in HBIO increased 29.85% quarter over quarter, and separately, investors owning Harvard Bioscience decreased 96.74% from a year ago.
- Activity in HBIO broke down as 1 buyers, 1 sellers, and 1 unchanged among 3 total holders.
- Institutional investors collectively held 236.05K shares in Harvard Bioscience as of March 2026, up by 54.26K shares quarter on quarter, and down 2.4Mn shares year over year.
- As of March 31, 2026, Meros Investment Management, LP held the largest stake in Harvard Bioscience with 118.52K shares, accounting for 2.65% of total shares outstanding.
- Top purchasers of HBIO stock for the quarter ending March 2026 included NANO CAP NEW MILLENNIUM GROWTH FUND L P (57.5K).
- The largest sellers of Harvard Bioscience for the quarter ending March 2026 were Meros Investment Management, LP (3.24K).
- Business Quant data shows the 3 biggest positions in Harvard Bioscience as of March 2026 are held by Meros Investment Management, LP (118.52K), NANO CAP NEW MILLENNIUM GROWTH FUND L P (117.5K), Financial Connections Group, Inc. (30).